Structural in silico analysis of cross-genotype-reactivity among naturally occurring HCV NS3-1073-variants in the context of HLA-A*02:01 allele

被引:20
作者
Antunes, Dinler A. [1 ]
Rigo, Mauricio M. [1 ]
Silva, Jader P. [1 ]
Cibulski, Samuel P. [1 ]
Sinigaglia, Marialva [1 ]
Chies, Jose A. B. [1 ]
Vieira, Gustavo F. [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Genet, NBLI, Porto Alegre, RS, Brazil
关键词
Cross-reactivity; Immunogenicity; Structural bioinformatics; Hepatitis C virus; HEPATITIS-C VIRUS; T-LYMPHOCYTE RESPONSES; INFECTION; PROTEIN; EPITOPE; DETERMINANTS; VACCINE; CELLS; INDIVIDUALS; PEPTIDES;
D O I
10.1016/j.molimm.2011.03.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cellular immune response plays a central role in outcome of Hepatitis C Virus (HCV) infection. While specific T-cell responses are related to viral clearance, impaired responses can lead to chronic infection, turning HCV variability into a major obstacle for vaccine development. In a recent work, Fytili et al. (2008) studied the cross reactive potential of HCV specific CD8+ T-cells and observed a large variation in immunogenicity among 28 naturally occurring NS3(1073) variants. In this work, we intend to evaluate this immunogenic variation at molecular level, through bioinformatics approaches. The D1-EM-D2 strategy was used to build in silico MHC: peptide complexes (pMHC) of these HCV-derived peptides in the context of HLA-A02:01 allele. The TCR-interacting surface of these complexes were evaluated using the GRASP2 program. Structural analysis indicated a sharing of topological and electrostatic features among complexes that induced strong response in vitro. Besides, complexes that induced low response presented an important positively charged spot in the center of TCR-interacting area. This spot was seen even in complexes with conservative amino acid changes and is consistent with the impairment of recognition by wild-type-specific T-cells, observed in vitro. Furthermore, the most remarkable difference in electrostatic potential was seen precisely in the only complex unable to induce in vitro stimulation. All these observations were confirmed by Principal Component Analysis (PCA) and this approach was also applied to a set of 45 non-related immunogenic viral epitopes, indicating possible new targets for cross-reactivity studies. Our results suggest structural in silico analysis of pMHC complexes as a reliable tool for vaccine development, affording to predict the impact of viral escape mutations and selection of epitopes with potential to induce cross-reactive immune responses. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1461 / 1467
页数:7
相关论文
共 38 条
  • [1] Principles of flexible protein-protein docking
    Andrusier, Nelly
    Mashiach, Efrat
    Nussinov, Ruth
    Wolfson, Haim J.
    [J]. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2008, 73 (02) : 271 - 289
  • [2] [Anonymous], 2009, J COMPUT CHEM
  • [3] Structural Allele-Specific Patterns Adopted by Epitopes in the MHC-I Cleft and Reconstruction of MHC:peptide Complexes to Cross-Reactivity Assessment
    Antunes, Dinler A.
    Vieira, Gustavo F.
    Rigo, Mauricio M.
    Cibulski, Samuel P.
    Sinigaglia, Marialva
    Chies, Jose A. B.
    [J]. PLOS ONE, 2010, 5 (04):
  • [4] Bremel Robert D, 2010, Immunome Res, V6, P7, DOI 10.1186/1745-7580-6-7
  • [5] Bremel Robert D, 2010, Immunome Res, V6, P8, DOI 10.1186/1745-7580-6-8
  • [6] Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection
    Cucchiarini, M
    Kammer, AR
    Grabscheid, B
    Diepolder, HM
    Gerlach, TJ
    Grüner, N
    Santantonio, T
    Reichen, J
    Pape, GR
    Cerny, A
    [J]. CELLULAR IMMUNOLOGY, 2000, 203 (02) : 111 - 123
  • [7] A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins
    Engler, OB
    Schwendener, RA
    Dai, WJ
    Wölk, B
    Pichler, W
    Moradpour, D
    Brunner, T
    Cerny, A
    [J]. VACCINE, 2004, 23 (01) : 58 - 68
  • [8] Cross-genotype-reactivity of the immunodominant HCVCD8 T-cell epitope NS3-1073
    Fytili, P.
    Dalekos, G. N.
    Schlaphoff, V.
    Suneetha, P. V.
    Sarrazin, C.
    Zauner, W.
    Zachou, K.
    Berg, T.
    Manns, M. P.
    Klade, C. S.
    Cornberg, M.
    Wedemeyer, H.
    [J]. VACCINE, 2008, 26 (31) : 3818 - 3826
  • [9] Structural Bases for the Affinity-Driven Selection of a Public TCR against a Dominant Human Cytomegalovirus Epitope
    Gras, Stephanie
    Saulquin, Xavier
    Reiser, Jean-Baptiste
    Debeaupuis, Emilie
    Echasserieau, Klara
    Kissenpfennig, Adrien
    Legoux, Francois
    Chouquet, Anne
    Le Gorrec, Madalen
    Machillot, Paul
    Neveu, Berangere
    Thielens, Nicole
    Malissen, Bernard
    Bonneville, Marc
    Housset, Dominique
    [J]. JOURNAL OF IMMUNOLOGY, 2009, 183 (01) : 430 - 437
  • [10] Immune Response of Cytotoxic T Lymphocytes and Possibility of Vaccine Development for Hepatitis C Virus Infection
    Hiroishi, Kazumasa
    Eguchi, Junichi
    Ishii, Shigeaki
    Hiraide, Ayako
    Sakaki, Masashi
    Doi, Hiroyoshi
    Omori, Risa
    Imawari, Andmichio
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,